Clarus Therapeutics Holdings, Inc.
- Dec 21, 2021 · D · $15,000,002 sold of $15,000,002 · 1 investors · min. No minimum reported · role: Executive Officer, Director EDGAR ↗
Raised $15M from 1 investor (100% of the $15M target) as of the latest filing. Robert is listed as executive officer, director.
Sources
Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Pharmaceuticals / 506(b) (800 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.